Anti-(Raf-1) RNA aptamers that inhibit Ras-induced Raf-1 activation.

RNA aptamers with affinity for the Ras-binding domain (RBD) of Raf-1 were isolated from a degenerate pool by in vitro selection. These aptamers efficiently inhibited the Ras interaction with the Raf-1 RBD, and also inhibited Ras-induced Raf-1 activation in a cell-free system. The RNA aptamer with the most potent inhibitory effect specifically inhibited the Ras-Raf-1 interaction and had no affinity for the RBD of the RGL protein, a homolog of the Ral GDP dissociation stimulator. Although the aptamer was capable of binding to the B-Raf RBD, the RNA did not inhibit the interaction between Ras and the B-Raf RBD. Enzymatic and chemical probing experiments indicated that the aptamer was folded into a pseudoknot structure, and some loop regions of the pseudoknot were located at the binding interface for the Raf-1 RBD.

[1]  T. Böhm,et al.  Controlling small guanine–nucleotide-exchange factor function through cytoplasmic RNA intramers , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[2]  W. Kolch.  Meaningful relationships: the regulation of the Ras/Raf/MEK/ERK pathway by protein interactions. , 2000, The Biochemical journal.

[3]  M. Famulok,et al.  Nucleic acid aptamers-from selection in vitro to applications in vivo. , 2000, Accounts of chemical research.

[4]  A. King,et al.  Regulation of the protein kinase Raf-1 by oncogenic Ras through phosphatidylinositol 3-kinase, Cdc42/Rac and Pak , 2000, Current Biology.

[5]  A. Ellington,et al.  RNA Aptamers That Bind to and Inhibit the Ribosome-inactivating Protein, Pepocin* , 2000, The Journal of Biological Chemistry.

[6]  K. Inouye,et al.  Formation of the Ras Dimer Is Essential for Raf-1 Activation* , 2000, The Journal of Biological Chemistry.

[7]  C. Herrmann,et al.  Mitogenic signaling of Ras is regulated by differential interaction with Raf isozymes , 2000, Oncogene.

[8]  A. Wittinghofer,et al.  Selection of phage‐displayed Fab antibodies on the active conformation of Ras yields a high affinity conformation‐specific antibody preventing the binding of c‐Raf kinase to Ras , 1999, FEBS letters.

[9]  J. Lis,et al.  RNA aptamers as effective protein antagonists in a multicellular organism. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Philip R. Cohen,et al.  Paradoxical activation of Raf by a novel Raf inhibitor. , 1999, Chemistry & biology.

[11]  S. Yokoyama,et al.  Double-mutant analysis of the interaction of Ras with the Ras-binding domain of RGL. , 1999, Biochemistry.

[12]  M. Famulok,et al.  Cytoplasmic RNA modulators of an inside-out signal-transduction cascade. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[13]  P. Cohen,et al.  Effect of SB 203580 on the activity of c-Raf in vitro and in vivo , 1999, Oncogene.

[14]  T. Kigawa,et al.  Solution structure of the Ras‐binding domain of RGL , 1998, FEBS letters.

[15]  S. Yokoyama,et al.  RNA aptamers that specifically bind to the Ras‐binding domain of Raf‐1 , 1998, FEBS letters.

[16]  M. Green,et al.  Controlling gene expression in living cells through small molecule-RNA interactions. , 1998, Science.

[17]  Channing J Der,et al.  Increasing complexity of Ras signaling , 1998, Oncogene.

[18]  S. Mizutani,et al.  Isolation of a new protein factor required for activation of Raf-1 by Ha-Ras: partial purification from rat brain cytosols , 1998, Oncogene.

[19]  S. Yokoyama,et al.  Interactions of the Amino Acid Residue at Position 31 of the c-Ha-Ras Protein with Raf-1 and RalGDS* , 1998, The Journal of Biological Chemistry.

[20]  C. Carles,et al.  Selective Targeting and Inhibition of Yeast RNA Polymerase II by RNA Aptamers* , 1997, The Journal of Biological Chemistry.

[21]  F. McCormick,et al.  Activation of c‐Raf‐1 by Ras and Src through different mechanisms: activation in vivo and in vitro , 1997, The EMBO journal.

[22]  C. Marshall,et al.  Differential Regulation of Raf-1, A-Raf, and B-Raf by Oncogenic Ras and Tyrosine Kinases* , 1997, The Journal of Biological Chemistry.

[23]  W. Kolch,et al.  Inhibition of Raf-1 signaling by a monoclonal antibody, which interferes with Raf-1 activation and with Mek substrate binding. , 1996, Oncogene.

[24]  Ralf Janknecht,et al.  Ras/Rap effector specificity determined by charge reversal , 1996, Nature Structural Biology.

[25]  S. Yokoyama,et al.  Difference in the mechanism of interaction of Raf-1 and B-Raf with H-Ras. , 1996, Biochemical and biophysical research communications.

[26]  A. Wittinghofer,et al.  Quantitative structure-activity analysis correlating Ras/Raf interaction in vitro to Raf activation in vivo , 1996, Nature Structural Biology.

[27]  Anthony J. Muslin,et al.  Ras‐interacting domain of RGL blocks Ras‐dependent signal transduction in Xenopus oocytes , 1996, FEBS letters.

[28]  Alfred Wittinghofer,et al.  Quantitative Analysis of the Complex between p21 and the Ras-binding Domain of the Human Raf-1 Protein Kinase (*) , 1995, The Journal of Biological Chemistry.

[29]  J. Bischoff,et al.  Identification of the guanine nucleotide dissociation stimulator for Ral as a putative effector molecule of R-ras, H-ras, K-ras, and Rap. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Troppmair,et al.  The ins and outs of Raf kinases. , 1994, Trends in biochemical sciences.

[31]  S. Demo,et al.  ralGDS family members interact with the effector loop of ras p21 , 1994, Molecular and cellular biology.

[32]  Michael J. Fry,et al.  Phosphatidylinositol-3-OH kinase direct target of Ras , 1994, Nature.

[33]  M. Shirouzu,et al.  Mutations that abolish the ability of Ha-Ras to associate with Raf-1. , 1994, Oncogene.

[34]  X. F. Zhang,et al.  Critical binding and regulatory interactions between Ras and Raf occur through a small, stable N-terminal domain of Raf and specific Ras effector residues , 1994, Molecular and cellular biology.

[35]  E. Nishida,et al.  Characterization of recombinant Xenopus MAP kinase kinases mutated at potential phosphorylation sites. , 1994, Oncogene.

[36]  M. Nakafuku,et al.  GTP-dependent association of Raf-1 with Ha-Ras: identification of Raf as a target downstream of Ras in mammalian cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Jonathan A. Cooper,et al.  Mammalian Ras interacts directly with the serine/threonine kinase raf , 1993, Cell.

[38]  E. Nishida,et al.  cDNA cloning of MAP kinase kinase reveals kinase cascade pathways in yeasts to vertebrates. , 1993, The EMBO journal.

[39]  J. Szostak,et al.  In vitro selection of RNA molecules that bind specific ligands , 1990, Nature.

[40]  L. Gold,et al.  Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. , 1990, Science.

[41]  D. Turner,et al.  Predicting optimal and suboptimal secondary structure for RNA. , 1990, Methods in enzymology.

[42]  T. Pawson,et al.  raf family serine/threonine protein kinases in mitogen signal transduction. , 1988, Cold Spring Harbor symposia on quantitative biology.

[43]  S. Hirohashi,et al.  Monoclonal antibody highly sensitive for the detection of ras p21 in immunoblotting analysis. , 1987, Japanese journal of cancer research : Gann.